Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 1694-1699, 2007. First published July 27, 2007; 10.1373/clinchem.2007.090027
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.090027v1
53/9/1694    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dodder, N. G.
Right arrow Articles by Welch, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dodder, N. G.
Right arrow Articles by Welch, M. J.
Related Collections
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2007;53:1694-1699.)
© 2007 American Association for Clinical Chemistry, Inc.

General Clinical Chemistry

Certification of Creatinine in a Human Serum Reference Material by GC-MS and LC-MS

Nathan G. Dodder1,a, Susan S.-C. Tai1, Lorna T. Sniegoski1, Nien F. Zhang2 and Michael J. Welch1

1 Analytical Chemistry Division and 2 Statistical Engineering Division, National Institute of Standards and Technology, Gaithersburg, MD.

aAddress correspondence to this author at: National Institute of Standards and Technology, 100 Bureau Dr., Stop 8392, Gaithersburg, MD 20899-8392. Fax 301-977-0685; e-mail nathan.dodder{at}nist.gov.

Background: To meet recommendations given by the Laboratory Working Group of the National Kidney Disease Education Program for improving serum creatinine measurements, NIST developed standard reference material (SRM) 967 Creatinine in Frozen Human Serum. SRM 967 is intended for use by laboratories and in vitro diagnostic equipment manufacturers for the calibration and evaluation of routine clinical methods.

Methods: The SRM was produced from 2 serum pools with different creatinine concentrations. The concentrations were certified using a higher-order isotope-dilution GC-MS method and an isotope-dilution LC-MS method. The LC-MS method is a potential higher-order reference measurement procedure.

Results: The GC-MS mean (CV) concentrations were 67.0 (0.9%) µmol/L for serum pool 1 and 346.1 (0.45%) µmol/L for serum pool 2. The LC-MS results were 66.1 (0.2%) µmol/L and 346.3 (0.2%) µmol/L, respectively. For serum pool 1, there was a 1.4% difference between the mean GC-MS and LC-MS measurements, and a 0.10% difference for serum pool 2. The results from the 2 methods were combined to give the certified concentrations and expanded uncertainties.

Conclusions: The certified concentration (expanded uncertainty) of SRM 967 was 66.5 (1.8) µmol/L for serum pool 1 (a value close to the diagnostically important concentration of 88.4 µmol/L) and 346.2 (7.4) µmol/L for serum pool 2 (a concentration corresponding to that expected in a patient with chronic kidney disease).




The following articles in journals at HighWire Press have cited this article:


Home page
 Nephrol Dial TransplantHome page
J. R. Delanghe
How to estimate GFR in children
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 714 - 716.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.